Ligand Pharmaceuticals (LGND) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ligand Pharmaceuticals

    NASDAQ: LGND · Real-Time Price · USD
    166.70
    -0.05 (-0.03%)
    At close: Sep 08, 2025, 12:26 PM

    Ligand Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -486.05 23.69 -215.9 44.96
    PEG Ratio
    		 4.53 -0.02 1.98 -0.02
    PS Ratio
    		 11.73 9.41 5.74 9.27
    PB Ratio
    		 2.36 1.76 1.89 3.13
    P/FCF Ratio
    		 20.58 -289.19 9.40 36.68
    P/OCF Ratio
    		 20.19 24.92 8.17 32.60
    OCF/S Ratio
    		 0.58 0.38 0.70 0.28
    Debt / Equity Ratio
    		 0.01 0.01 0.15 0.41
    Quick Ratio
    		 8.55 12.72 2.53 10.50
    Current Ratio
    		 8.93 14.15 2.67 11.15
    Asset Turnover
    		 0.18 0.17 0.26 0.21
    Interest Coverage
    		 -7.44 18.20 -14.18 4.02
    Return on Equity
    		 n/a 0.07 -0.01 0.07
    Return on Assets
    		 n/a 0.07 -0.01 0.04
    Return on Invested Capital
    		 0.04 0.01 n/a 0.08
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.93 0.73 0.73 0.78
    Net Profit Margin
    		 -0.02 0.40 -0.03 0.21
    Pretax Profit Margin
    		 0.02 0.48 0.18 0.17
    Operating Profit Margin
    		 -0.14 0.09 -0.13 0.28
    FCF Margin
    		 0.57 -0.03 0.61 0.25
    EBITDA Margin
    		 0.24 0.77 0.28 0.48

    Add to Watchlist